Is Agomelatine Associated with Less Sedative-Hypnotic Usage in Patients with Major Depressive Disorder? A Nationwide, Population-Based Study
Shih-Chun Hsing,1,2 Yo-Ting Jin,3,4 Nian-Sheng Tzeng,5,6 Chi-Hsiang Chung,7– 9 Tien-Yu Chen,5,10,11 Hsin-An Chang,5,6 Yu-Chen Kao,5,12 Wu-Chien Chien4,7– 9 1Center for Healthcare Quality Management, Cheng Hsin General Hospital, Taipei, Taiwan; 2Department of Health Care Managemen...
Saved in:
| Main Authors: | Hsing SC, Jin YT, Tzeng NS, Chung CH, Chen TY, Chang HA, Kao YC, Chien WC |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Dove Medical Press
2020
|
| Subjects: | |
| Online Access: | https://doaj.org/article/8741e2f298ae4b1bb53d92aedb54cef4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oral bioavailability enhancement of agomelatine by loading into nanostructured lipid carriers: Peyer’s patch targeting approach
by: Prajapati JB, et al.
Published: (2018) -
Low-Frequency versus High-Frequency Ultrasound-Mediated Transdermal Delivery of Agomelatine-Loaded Invasomes: Development, Optimization and in-vivo Pharmacokinetic Assessment
by: Tawfik MA, et al.
Published: (2020) -
Agomelatine versus paroxetine in treating depressive and anxiety symptoms in patients with chronic kidney disease
by: Chen JW, et al.
Published: (2018) -
Agomelatine in the treatment of mild-to-moderate depression in patients with cardiovascular disease: results of the national multicenter observational study PULSE
by: Medvedev VE
Published: (2017) -
Mind your state: Insights into antidepressant nonadherence
by: De Wet Wolmarans, et al.
Published: (2016)